top of page

Lunaphore acquired by Bio-Techne Corporation


three people standing in front of a building
Lunaphore founders Déborah Heintze, Ata Tuna Ciftlik, and Diego Gabriel Dupouy


We are thrilled to announce that our portfolio company, Switzerland-based Lunaphore Technologies (RAC II), has been acquired by global life sciences company Bio-Techne Corporation.


Lunaphore’s vision is to enable spatial biology in every laboratory. Their innovative technology helps identify biomarker “signatures” with clinical relevance, supporting the development of diagnostic tools and streamlining clinical trials to ultimately improve patient outcomes. The acquisition follows a recent strategic partnership between Bio-Techne and Lunaphore, focused on the development of the first fully automated spatial multiomic workflow. 

Michael Sidler, Partner at Redalpine, said: "As the first professional investor in Lunaphore, we are thrilled to have empowered this game changer from start to exit by providing support in strategy, recruiting, fundraising, and more. With the fusion of diagnostics and precision engineering, fueled by the vibrant ecosystem surrounding École Polytechnique Fédérale de Lausanne, Lunaphore possesses the unique ingredients for success and we’re convinced they will continue to revolutionize the emerging field of spatial biology. Their acquisition by Bio-Techne serves as a powerful validation of Redalpine’s sector-agnostic investment strategy, which ensures the resilience of our portfolio and consistently delivers high returns to our investors."


“We are truly excited to be joining Bio-Techne and combining capabilities to lead the Spatial Biology market,” said Dr. Ata Tuna Ciftlik, CEO of Lunaphore. “Our shared vision of tackling the translational and clinical research market, while using our complementary best-in-class spatial proteomics and transcriptomics products is going to make a great impact on our customers in advancing research. In addition, Bio-Techne’s global reach, and commercial and operational excellence will enable Lunaphore to accelerate its penetration into the high-growth spatial biology market. We’re now joining forces to be the largest spatial biology player.”


We extend our heartfelt congratulations to the entire Lunaphore team and are proud to play a role in their remarkable journey. We look forward to witnessing their continued innovation in the field of spatial biology, now supported by the vast resources and expertise of Bio-Techne.

Comments


bottom of page